Japan Pharma

Text search

Sort by Default

Display 15 Products per page

Company Analysis: Shionogi

$3,000.00

PharmaVitae explores Shionogi’s prescription pharmaceutical performance and outlook through to 2029.
January 29, 2021
Find out more
Company Analysis: Takeda

$3,000.00

PharmaVitae explores Takeda’s prescription pharmaceutical performance and outlook over 2019–29.
January 29, 2021
Find out more
Company Analysis: Ono Pharmaceutical

$3,000.00

PharmaVitae explores Ono Pharmaceutical’s prescription pharmaceutical performance and outlook over 2019–29.
January 29, 2021
Find out more
Company Analysis: Mitsubishi Tanabe

$3,000.00

PharmaVitae explores Mitsubishi Tanabe’s prescription pharmaceutical performance and outlook over 2019–29.
January 29, 2021
Find out more
Company Analysis: Eisai

$3,000.00

PharmaVitae explores Eisai’s prescription pharmaceutical performance and outlook over 2019–29.
January 28, 2021
Find out more
Company Analysis: Sumitomo Dainippon

$3,000.00

PharmaVitae explores Sumitomo Dainippon’s prescription pharmaceutical performance and outlook over 2019–29.
January 28, 2021
Find out more
Company Analysis: Daiichi Sankyo

$3,000.00

PharmaVitae explores Daiichi Sankyo’s prescription pharmaceutical performance and outlook over 2019–29.
January 28, 2021
Find out more
Company Analysis: Astellas

$3,000.00

PharmaVitae explores Astellas’s prescription pharmaceutical performance and outlook over 2019–29.
January 28, 2021
Find out more
Company Analysis: Kyowa Kirin

$3,000.00

PharmaVitae explores Kyowa Kirin’s prescription pharmaceutical performance and outlook over 2019–29.
January 28, 2021
Find out more
Company Analysis: Otsuka

$3,000.00

PharmaVitae explores Otsuka’s prescription pharmaceutical performance and outlook over 2019–29.
January 29, 2020
Find out more
Shire Company Analysis

$3,000.00

PharmaVitae explores Shire’s prescription pharmaceutical performance and outlook over 2017–27. PharmaVitae analyses include quarterly earnings coverage and provide timely updates to company product forecasts
August 30, 2018
Find out more
Japan Pharma Outlook 2027

$3,000.00

PharmaVitae explores and visualizes market dynamics in the Japan Pharma peer set out to 2027* through analysis and in-house sales forecasts for more than 320 products.
July 2, 2018
Find out more
Japan Pharma Outlook

$3,000.00

Datamonitor’s Japan Pharma peer set contains the top 10 companies headquartered in Japan: Takeda Pharmaceuticals, Astellas Pharma, Daiichi Sankyo, Otsuka Pharmaceutical, Eisai, Mitsubishi Tanabe Pharma, Chugai Pharmaceutical, Dainippon Sumitomo, Shionogi & Co and Kyowa Hakko Kirin.
September 28, 2016
Find out more

Sign up to the Pharma Intelligence Report Store Newsletter to get the latest blogs, news, reports and discounts!

Pharma Intelligence

Pharma Intelligence UK Limited is a company registered in England and Wales with company number 13787459 whose registered office is Suite 1, 3rd Floor, 11 - 12 St. James's Square, London, England, SW1Y 4LB. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

Call Back

Name

Email *

Company name *

Phone number *